Danaila L, Radoi M
Neurosurgical Department, National Institute of Neurology and Neurovascular Diseases, Bucharest, Romania.
Chirurgia (Bucur). 2013 Jul-Aug;108(4):456-62.
The third ventricle is located in the center of the brain, surrounded by critical structures. The authors reported their experience in the surgical treatment of tumors originated from or expanding within the third ventricle, analysing the postoperative results and patient's outcome.
We performed a retrospective study on 120 patients, who had been operated in our neurosurgical department for tumors of the third ventricle and adjacent region over the last 21 years. According to their place of origin, these tumors were divided into primary tumors of the third ventricle (69 cases) and tumors developed from the surrounding structures (51 cases). The patients were operated on via a transcallosal-transventricular approach (58.34%), transcortical parieto-occipital approach (26.67%) or subfrontal approach (15%). Microsurgery has been used in all cases. In 20 patients (16.67%), preoperative ventricular drainage was performed. Stereotactic procedures were not used in this study.
The overall mortality in this series was 11.67% (14 120 died). The death was directly correlated to the surgery in 8 cases, to general complications in 3 cases, to recurrence of the tumor in 2 cases, and to shunt malfunction in one case. Perioperative good evolution (GOS 5) was noted in 54 patients (45%), but at one-year follow-up, good neurological evolution was recorded in 72 patients (60%). The long-term neurological outcome recorded neurological impairments in 21.42% of patients, a permanent diabetes insipidus in 5.1% of patients and the persistence of neuropsychological deficits in 28.57%. The recurrence of the tumor has been encountered in 16 patients (13.34%).
Transcallosal approach remains the best method for the microneurosurgical treatment of third ventricle tumors. This route provides the capability for a superior visualization of the entire cavity of the third ventricle through different corridors, and permanent neurological and neuropsychological deficits are not frequent.
第三脑室位于脑中心,周围环绕着重要结构。作者报告了他们对起源于第三脑室或在第三脑室内扩展的肿瘤进行手术治疗的经验,分析了术后结果和患者预后。
我们对过去21年在我院神经外科接受第三脑室及邻近区域肿瘤手术的120例患者进行了回顾性研究。根据肿瘤起源部位,这些肿瘤分为第三脑室原发性肿瘤(69例)和起源于周围结构的肿瘤(51例)。患者通过经胼胝体 - 脑室入路(58.34%)、经皮质顶枕入路(26.67%)或额下入路(15%)进行手术。所有病例均采用显微手术。20例患者(16.67%)术前进行了脑室引流。本研究未使用立体定向手术。
本系列患者的总死亡率为11.67%(120例中有14例死亡)。8例死亡与手术直接相关,3例与全身并发症相关,2例与肿瘤复发相关,1例与分流故障相关。54例患者(45%)围手术期病情进展良好(GOS 5),但在一年随访时,72例患者(60%)神经功能进展良好。长期神经学结果显示,21.42%的患者存在神经功能障碍,5.1%的患者存在永久性尿崩症,28.57%的患者存在神经心理学缺陷持续存在。16例患者(13.34%)出现肿瘤复发。
经胼胝体入路仍然是第三脑室肿瘤显微神经外科治疗的最佳方法。该入路能够通过不同通道更好地观察第三脑室的整个腔隙,永久性神经和神经心理学缺陷并不常见。